2022
DOI: 10.1016/j.phrs.2022.106249
|View full text |Cite
|
Sign up to set email alerts
|

An overview of CDK3 in cancer: clinical significance and pharmacological implications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 115 publications
1
2
0
Order By: Relevance
“…CDK3 is a significant driver in retinoblastoma (Rb) phosphorylation during the G0/G1 transition of the cell cycle. The expression of CDK3 is deficient in normal tissue but overexpressed in many cancers 50 . In our research, CDK3 was upregulated in OS tissue, and downregulating of CDK3 would inhibit the proliferation and migration capabilities of OS cells.…”
Section: Discussionsupporting
confidence: 45%
See 1 more Smart Citation
“…CDK3 is a significant driver in retinoblastoma (Rb) phosphorylation during the G0/G1 transition of the cell cycle. The expression of CDK3 is deficient in normal tissue but overexpressed in many cancers 50 . In our research, CDK3 was upregulated in OS tissue, and downregulating of CDK3 would inhibit the proliferation and migration capabilities of OS cells.…”
Section: Discussionsupporting
confidence: 45%
“…The expression of CDK3 is deficient in normal tissue but overexpressed in many cancers. 50 In our research, CDK3 was upregulated in OS tissue, and downregulating of CDK3 would inhibit the proliferation and migration capabilities of OS cells. Thus, we speculated that the overexpression of CDK3 in OS might correlate with mechanisms of proliferation and migration.…”
Section: Discussionmentioning
confidence: 55%
“…Cyclin A, C, E Promotes G0/G1 and G1/S transitions (Ren & Rollins, 2004;Sage, 2004;Satyanarayana & Kaldis, 2009b;Teo et al, 2022;van den Heuvel & Harlow, 1993;Ye et al, 2001) Targets transcriptional repressor Rb (Hofmann & Livingston, 1996;Ren & Rollins, 2004) Phosphorylates c-Jun and ATF1 to simulate cell transformation (Cho et al, 2009;Zheng et al, 2008) Promotes apoptosis (Meikrantz & Schlegel, 1996) Promotes EMT (Lu et al, 2016) CDK5 p35, p38 Blocks cell cycle in postmitotic neurons (Cicero & Herrup, 2005;Zhang et al, 2008) Promotes proliferation in neuroendocrine thyroid cancer (Pozo et al, 2013) Implicated in transcriptional programs for neuronal differentiation (Cicero & Herrup, 2005) Activates STAT3 (A. K. Y. Fu et al, 2004) Inhibits MEF2 to promote apoptosis (Gong et al, 2003) Activates mSds3 to promote histone acetylation (Z.…”
Section: Cdk3mentioning
confidence: 99%